NCT06099873 - Study to Assess the Safety and Efficacy of ZX-7101A in Adolescents With Influenza | Biotech Hunter

Enrollment

361

Participants

Timeline

Start Date

November 30, 2023

Primary Completion Date

February 13, 2025

Study Completion Date

February 13, 2025

Conditions

Respiratory Viral Infection

Interventions

DRUG

ZX-7101A

Day1 Take one tablet of ZX-7101A orally once (specification: 40mg/ tablet) with appropriate amount of warm water

DRUG

Placebo

Day1 Take one tablet of Placebo orally once with appropriate amount of warm water

Trial Locations (1)

Fudan University affiliated Huashan Hospital, Shanghai